呋塞米

fū sāi mǐ
  • Furosemide
呋塞米呋塞米
  1. 目的:建立血浆中呋塞米(速尿)简便敏感的HPLC测定方法。

    OBJECTIVE : To establish a simple , sensitive RP HPLC method of furosemide ( FSM ) determination .

  2. 方法:通过对盐酸多巴胺、呋塞米、甲磺酸酚妥拉明在生理盐水中配伍后外观色泽的观察、溶液pH以及吸收值的测定来探讨引起盐酸多巴胺溶液不稳定的因素。

    Method : To observe the color and transparency and to determine the values of pH and absorbance of normal saline containing dopamine together with furosemide and phentolamine mesylate in order to determine the instable factors to dopamine solution .

  3. Ce(Ⅳ)-Na2S2O4-呋塞米化学发光体系的研究

    Study on Chemiluminescence System of Ce ( IV ) - Na_2S_2O_4-Furosemide

  4. 两组均给予优思弗治疗,肝功能转氨酶较高者加用五酯胶囊,HBVdna阳性达到抗病毒治疗者行常规抗病毒治疗,有腹水者适当给予呋塞米及螺内酯行利水处理。

    Two groups were given UDCA therapy , the higher liver transaminase plus five capsules , HBV DNA positive to anti-viral therapy with conventional anti-viral treatment , with ascites is appropriate , given the line of furosemide and spironolactone treatment benefit .

  5. 结果:与治疗前比较,阿佐塞米组治疗后24h尿量明显增加,伴随体质量显著下降[(3.3±3.6)kg],与呋塞米组相似;

    Results : After treatment , 24 h urine volume in azosemide group increased markedly and body weight decreased by ( 3.3 ± 3.6 ) kg , the same was true to furosemide group .

  6. 术后18人出现少尿时iv山莨菪碱91±27(60~120)mg/d、呋塞米与免疫抑制剂(治疗组)。

    Other 18 patients with oliguria were injected iv with anisodamine 91 ± 27 ( 60-120 ) mg / d and furosemide 142 ± 71 ( 60-200 ) mg / d for 4-10 d , and immunosuppressant , the former both drugs wee alternated use ( treatment group ) .

  7. 结论大剂量呋塞米和小剂量高渗盐溶液治疗难治性心力衰竭能很快达到干体重,明显降低BNP水平,心功能得到迅速改善,明显降低30d内的再住院率和病死率。

    Conclusion The high-dose furosemide and small-volume HSS group reached dry weight more rapidly , significantly faster reduction in BNP levels and improvement in advanced CHF patients , lower incidence in readmissions and fatality rate in the 30-day study period .

  8. 同样方法以生理盐水、呋塞米片为对照。

    Compare with physiological saline and furosemide by the same method .

  9. 本研究期间患者接受固定剂量的呋塞米。

    Patients received furosemide in a stable dose throughout the study .

  10. 吸入呋塞米对支气管哮喘病人气道反应性的影响

    Effects of inhaled furosemide on bronchial responsiveness in patients with asthma

  11. 血浆呋塞米的高效液相色谱法测定及应用

    Determination of furosemide in plasma with HPLC and its application

  12. 雾化吸入呋塞米在健康小鼠体内的药动学研究

    Pharmacokinetic Study on Atomization Inhalation Furosemide in Healthy Mice

  13. 呋塞米联合甘露醇治疗急性肢体肿胀临床疗效观察

    United Application of Furosemide and Mannitol on Acute Swelling Limb : Clinical Analysis

  14. 持续静脉微量注射呋塞米对严重充血性心力衰竭患者治疗效果

    The application of furosemide by microinfusion pump continually in severe congestive heart failure

  15. 早期应用呋塞米(速尿)预防早产儿肺透明膜病的临床观察

    Clinic observing the effect of Furosemide in prevention hyaline membrane disease of preterm infant

  16. 吸入呋塞米对急性发作期支气管哮喘患者肺通气功能的影响

    Effect of inhaled furosemide on lung function in patients with acute exacerbation of asthma

  17. 大剂量呋塞米联合多巴胺静脉泵入治疗顽固性心力衰竭32例

    Pumping high dose of furosemide combined with dopamine for treatment of intractable heart failure

  18. 结论国产托拉塞米片治疗水肿性疾病利尿效果显著,不良反应较小,与呋塞米片无显著差异。

    CONCLUSION Torasemide tablet is an effective and safe drug in treatment of edema diseases .

  19. 静脉泵注呋塞米在危重症治疗中的临床效果

    The clinical effect of continuous using Furosemide through vein by micro pump in critical patients

  20. 在我们研究的人群中等渗盐水、呋塞米和皮下给予降钙素具有良好的耐受性和有效性。

    Isotonic saline , furosemide and s.c.calcitonin were well-tolerated and effective treatments in our study population .

  21. 结论:呋塞米佐治新生儿湿肺有确切疗效。

    Conclusions : Furosemide assistance treatment is effectual in clinical treatment on wet lung of the newborn .

  22. 大剂量呋塞米持续静脉输注与单次及分次静脉注射在难治性心力衰竭治疗中的疗效观察

    Efficacy of high dose furosemide with continuous infusion , single or double injection in refractory heart failure

  23. 结论:大剂量呋塞米强化利尿可显著增加利尿效果,改善心脏功能,其中持续静脉输注组疗效显著优于分次静脉注射组和单次静脉注射组。

    CONCLUSION Aggressive treatment with furosemide can increase the efficacy of diuresis and improve the heart function .

  24. 持续静滴与静注呋塞米治疗原发性肾病综合征患儿水肿的对比研究

    Comparison of continuous versus intermittent furosemide infusion in the treatment for edema in pediatric patients with nephrotic syndrome

  25. 托拉塞米与呋塞米对急性心力衰竭患者尿量及电解质影响比较

    Comparison with effects of torasemide and furosemide on urine volume and electrolytes in patients with acute heart failure

  26. 腹水静脉回输联合多巴胺及呋塞米治疗肝硬化顽固性腹水36例

    Stubborn Ascites Resulting from Hepatocirrhosis Was Treated with Back Transfusion of Ascites plus Dopamine and Furosemide in 36 Patients

  27. 结论静脉滴注呋塞米治疗心力衰竭的利尿效果优于静脉推注。

    Conclusion The treatment of intravenous furosemide on heart failure of diuretic effect is better than intravenous injection furosemide .

  28. 呋塞米吸入治疗对老年慢性哮喘患者肺功能和外周血T淋巴细胞亚群的影响

    Effect of inhaled furosemide on pulmonary function and T lymphocyte subsets in peripheral blood in aged patients with chronic asthma

  29. 静脉注射6%羟乙基淀粉130/0.4和呋塞米治疗急性胰腺炎的初步研究

    Preliminary study on the treatment of acute pancreatitis by 6 % hydroxyethylstarch 130 / 0.4 ( Voluven ) and furosemide

  30. 目的观察肝硬化顽固性腹水病人应用自体腹水分次回输联合多巴胺及呋塞米的治疗效果。

    Objective To observe the therapeutic effect of self-ascites back transfusion plus dopamine and furosemide on stubborn ascites resulting from hepatocirrhosis .